Two balance-sheet ratios against market capitalisation and a test on the line of business, run across every listed US company over a billion dollars. Screened on AAOIFI’s limits, which are the strictest of the five published sets — a company clearing them clears the other four on these ratios as well.
Enter an ETF and every holding is put through the same screen as a company’s report. The result is the share of the fund’s money that passes, fails, or could not be screened — and how much each of the five standards would exclude on its own.
Needs live data. Fund holdings are read live; without a connection there is nothing to screen.
ARK Genomic Revolution ETF (ARKG) is not a Shariah-compliant fund: 18.3% of its weight is in companies that fail the Shariah screen, through their line of business or their debt and cash. 72.5% passes and 9.1% could not be screened.
| Holding | Weight | Why |
|---|---|---|
| BEAM BEAM THERAPEUTICS INC | 3.7% | Cash and short-term investments 48.3% of market cap |
| RXRX RECURSION PHARMACEUTICALS-A | 2.6% | Cash and short-term investments 37.2% of market cap |
| NRIX NURIX THERAPEUTICS INC | 2.3% | Cash and short-term investments 66.0% of market cap |
| NTLA INTELLIA THERAPEUTICS INC | 1.9% | Cash and short-term investments 34.6% of market cap |
| IONS IONIS PHARMACEUTICALS INC | 1.5% | Debt 42.4% of market cap; Cash and short-term investments 42.0% of market cap |
| ARCT ARCTURUS THERAPEUTICS HOLDIN | 1.4% | Cash and short-term investments 81.5% of market cap |
ARK Genomic Revolution ETF (ARKG) is not a Shariah-compliant fund: 18.3% of its weight is in companies that fail the Shariah screen, through their line of business or their debt and cash. 72.5% passes and 9.1% could not be screened.
72.5% of the fund's weight (19 of 34 holdings) is in companies that pass; 18.3% (11 holdings) fails; 9.1% (4 lines) could not be screened.
The largest are BEAM (3.7%), RXRX (2.6%), NRIX (2.3%), NTLA (1.9%), IONS (1.5%), ARCT (1.4%), SCTX (1.3%), PACB (1.2%), among 11 in all. Banks, insurers, credit and asset managers, alcohol, tobacco and gambling are excluded on their business; the others carry debt or cash above 30% of their market value.
Funds with a Shariah mandate screen their holdings and purify their income: SPUS, HLAL, UMMA, SPTE, SPWO. Each has its own page here, with the same holding-by-holding check.
Each holding goes through the halal stock screener's test: interest-bearing debt and cash plus short-term investments each under 30% of market cap (AAOIFI's limits, the strictest of the five published sets), and a line of business that is not excluded. Holdings are as the fund reported them on November 17, 2026; companies listed outside the US, cash, bonds and derivatives are not screened.
Shariah funds checked the same way: Is SPUS halal?, Is HLAL halal?, Is UMMA halal?, Is SPTE halal?, Is SPWO halal?. All halal ETFs compared. Run all five published standards on this fund with the check below.
A mechanical screen of published financial ratios and each company's line of business, not a religious ruling. It does not test income from excluded activities; check with a scholar you trust.
| SCTX SCRIBE THERAPEUTICS INC |
| 1.3% |
| Cash and short-term investments 58.3% of market cap |
| PACB PACIFIC BIOSCIENCES OF CALIF | 1.2% | Debt 111.6% of market cap; Cash and short-term investments 35.2% of market cap |
| FRNM FREENOME INC | 1.0% | Debt 236.8% of market cap; Cash and short-term investments 43.7% of market cap |
| GENB GENERATE BIOMEDICINES INC | 0.98% | Cash and short-term investments 32.0% of market cap |
| QSI QUANTUM-SI INC | 0.44% | Cash and short-term investments 46.8% of market cap |